View Item 

Show simple item record

Respiratory therapies for amyotrophic lateral sclerosis: A primer

dc.contributor.authorGruis, Kirsten L.en_US
dc.contributor.authorLechtzin, Noahen_US
dc.date.accessioned2012-09-05T14:46:02Z
dc.date.available2013-10-18T17:47:29Zen_US
dc.date.issued2012-09en_US
dc.identifier.citationGruis, Kirsten L.; Lechtzin, Noah (2012). "Respiratory therapies for amyotrophic lateral sclerosis: A primer." Muscle & Nerve 46(3): 313-331. <http://hdl.handle.net/2027.42/93524>en_US
dc.identifier.issn0148-639Xen_US
dc.identifier.issn1097-4598en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/93524
dc.description.abstractRespiratory complications are a common cause of morbidity and mortality in amyotrophic lateral sclerosis (ALS). Treatment of respiratory insufficiency with noninvasive ventilation (NIV) improves ALS patients' quality of life and survival. Evidence‐based practice guidelines for the management of ALS patients recommend treatment of respiratory insufficiency with NIV as well as consideration of insufflation/exsufflation to improve clearance of airway secretions. Despite these recommendations respiratory therapies remain underused. In this review we provide a practical guide for the clinician to prescribe and manage respiratory therapies for the patient with ALS. Muscle Nerve 46: 313–331, 2012en_US
dc.publisherWiley Subscription Services, Inc., A Wiley Companyen_US
dc.subject.otherNoninvasive Ventilationen_US
dc.subject.otherAmyotrophic Lateral Sclerosisen_US
dc.subject.otherMechanical Insufflation‐Exsufflationen_US
dc.subject.otherPractical Guideen_US
dc.subject.otherRespiratory Therapyen_US
dc.titleRespiratory therapies for amyotrophic lateral sclerosis: A primeren_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelNeurosciencesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Neurology, University of Michigan, 1C327 UH, EMG Lab, SPC 5036, 1500 E. Medical Center Drive, Ann Arbor, Michigan 48109, USAen_US
dc.contributor.affiliationumDepartment of Neurology, University of Michigan, 1C327 UH, EMG Lab, SPC 5036, 1500 E. Medical Center Drive, Ann Arbor, Michigan 48109, USAen_US
dc.contributor.affiliationotherPulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205, USAen_US
dc.identifier.pmid22907221en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/93524/1/23282_ftp.pdf
dc.identifier.doi10.1002/mus.23282en_US
dc.identifier.sourceMuscle & Nerveen_US
dc.identifier.citedreferenceSancho J, Servera E, Diaz J, Marin J. Efficacy of mechanical insufflation‐exsufflation in medically stable patients with amyotrophic lateral sclerosis. Chest 2004; 125: 1400 – 1405.en_US
dc.identifier.citedreferenceBaker WL, Lamb VJ, Marini JJ. Breath‐stacking Increases the depth and duration of chest expansion by incentive spirometry. Am Rev Respir Dis 1990; 141: 343 – 346.en_US
dc.identifier.citedreferenceRobinson R. 'Breath stacking' reported to make swallowing safer in ALS. Neurol Today 2011; 11: 12.en_US
dc.identifier.citedreferenceCleary S, Misiaszek J, Wheeler S, Kalra S, Johnston W. Using lung volume recruitment therapy to improve swallowing and airway pretection for individuals with ALS. Amyotroph Lateral Scler 2011; 11 ( Suppl 1 ): 58en_US
dc.identifier.citedreferenceBach JR. Mechanical Insufflation Exsufllation. Comparison of peak expiratory flows with manually assisted and unassisted coughing techniques. Chest 1993; 104: 1553 – 1562.en_US
dc.identifier.citedreferenceToussaint M, Boitano LJ, Gathot V, Steens M, Soudon P. Limits of effective cough‐augmentation techniquest in patients with neuromuscular disease. Respir Care 2009; 54: 359 – 366.en_US
dc.identifier.citedreferenceYankaskas JR, Marshall BC, Sufian B, Simon RH, Rodman D. Cystic fibrosis adult care: consensus conference report. Chest 2004; 125: 1S – 39S.en_US
dc.identifier.citedreferenceChaisson KM, Walsh S, Simmons Z, Vender RL. A clinical pilot study: high frequency chest wall oscillation airway clearance in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2006; 7: 107 – 111.en_US
dc.identifier.citedreferenceLange DJ, Lechtzin N, Davey C. High‐frequency chest wall oscillation in ALS: an exploratory randomized, controlled trial. Neurology 2006; 67: 991 – 997.en_US
dc.identifier.citedreferenceOnders RP, Elmo M, Khansarinia S, Bowman B, Yee J, Road J, et al. Complete worldwide operative experience in laparoscopic diaphragm pacing: results and differences in spinal cord injured patients and amyotrophic lateral sclerosis patients. Surg Endosc 2009; 23: 1433 – 1440.en_US
dc.identifier.citedreferenceBach JR, Bianchi C, Aufiero E. Oximetry and indications for tracheotomy for amyotrophic lateral sclerosis. Chest 2004; 126: 1502 – 1507.en_US
dc.identifier.citedreferenceBradley MD, Orrell RW, Clarke J, Davidson AC, Williams J, Kullmann DM, et al. Outcome of ventilatory support for acute respiratory failure in motor neuron disease. J Neurol Neurosurg Psychiatry 2002; 72: 752 – 756.en_US
dc.identifier.citedreferenceKuhnlein P, Kubler A, Raubold S, Worrell M, Kurt A, Gdynia H‐J, et al. Palliative care and circumstances of dying in German ALS patients using non‐invasive ventilation. Amyotroph Lateral Scler 2008; 9: 91 – 98.en_US
dc.identifier.citedreferenceNeudert C, Oliver D, Wasner M, Borasio GD. The course of the terminal phase in patients with amyotrophic lateral sclerosis. J Neurol 2001; 248: 612 – 616.en_US
dc.identifier.citedreferenceMoss AH, Oppenheimer EA, Casey P, Cazzolli PA, Roos RP, Stocking CB, et al. Patients with amyotrophic lateral sclerosis receiving long‐term mechanical ventilation. Chest 1996; 110: 249 – 255.en_US
dc.identifier.citedreferenceKaub‐Wittemer D, von Steinbuchel N, Wasner M, Laier‐Groeneveld G, Borasio GD. Quality of life and psychosocial issues in ventilated patients with amyotrophic lateral sclerosis and their caregivers. J Pain Symptom Manage 2003; 26: 890 – 896.en_US
dc.identifier.citedreferenceRabkin JG, Albert SM, Tider T, Del Bene ML, O'Sullivan I, Rowland LP, et al. Predictors and course of elective long‐term mechanical ventilation: a prospective study of ALS patients. Amyotroph Lateral Scler 2006; 7: 86 – 95.en_US
dc.identifier.citedreferenceChio A, Calvo A, Ghiglione P, Mazzini L, Mutani R, More G. Tracheostomy in amyotrophic lateral sclerosis: a 10‐year population‐based study in Italy. J Neurol Neurosurg Psychiatry 2010; 81: 1141 – 1143.en_US
dc.identifier.citedreferenceVianello A, Arcaro G, Palmieri A, Ermani M, Braccioni F, Gallan F, et al. Survival and quality of life after tracheostomy for acute respiratory failure in patients with amyotrophic lateral sclerosis. J Crit Care 2011; 26: 329.e7 – 329.e14.en_US
dc.identifier.citedreferenceLo Coco D, Marchese S, La Bella V, Piccoli T, Lo Coco A. The amyotrophic lateral sclerosis functional rating scale predicts survival time in amyotrophic lateral sclerosis patients on invasive mechanical ventilation. Chest 2007; 132: 64 – 69.en_US
dc.identifier.citedreferenceGelinas DF, O'Connor P, Miller RG. Quality of life for ventilator‐dependent ALS patients and their caregivers. J Neurol Sci 2008; 160 ( Suppl 1 ): S134 – S136.en_US
dc.identifier.citedreferenceHayashi H, Oppenheimer EA. ALS patients on TPPV. Totally locked‐in state, neurologic findings and ethical implications. Neurology 2003; 61: 135 – 137.en_US
dc.identifier.citedreferenceBorasio GD, Voltz R. Discontinuation of mechanical ventilation in patients with amyotrophic lateral sclerosis. J Neurol 1998; 245: 717 – 722.en_US
dc.identifier.citedreferencede Carvalho M, Pinto S, Swash M. Association of paraspinal and diaphragm denervation in ALS. Amyotroph Lateral Sclerosis 2010; 11: 63 – 66.en_US
dc.identifier.citedreferenceUldry C, Fitting JW. Maximal values of sniff nasal inspiratory pressure in healthy subjects. Thorax 1995; 50: 371 – 375.en_US
dc.identifier.citedreferenceKurian KM, Forbes RB, Colville S, Swingler RJ. Cause of death and clinical grading criteria in a cohort of amyotrophic lateral sclerosis cases undergoing autopsy from the Scottish Motor Neurone Disease Register. J Neurol Neurosurg Psychiatry 2009; 80: 84 – 87.en_US
dc.identifier.citedreferenceCorcia P, Pradat PF, Salachas F, Bruneteau G, Forestier N, Seilhean D, et al. Causes of death in a post‐mortem series of ALS patients. Amyotroph Lateral Scler 2008; 9: 59 – 62.en_US
dc.identifier.citedreferenceBergofsky EH. Respiratory failure in disorders of the thoracic cage. Am Rev Respir Dis 1979; 119: 643 – 669.en_US
dc.identifier.citedreferenceDe Troyer A, Borenstein S, Cordier R. Analysis of lung volume restriction in patients with respiratory muscle weakness. Thorax 1980; 35: 603 – 610.en_US
dc.identifier.citedreferencePinto AC, Evangelista T, de Carvalho M, Alves MA, Sales Luis ML. Respiratory assistance with a non‐invasive ventilator (Bipap) in MND/ALS patients: survival rates in a controlled trial. J Neurol Sci 1995; 129 ( Suppl ): 19 – 26.en_US
dc.identifier.citedreferenceAboussouan LS, Khan SU, Meeker DP, Stelmach K, Mitsumoto H. Effect of noninvasive positive‐pressure ventilation on survival in amyotrophic lateral sclerosis. Ann Intern Med 1997; 127: 450 – 453.en_US
dc.identifier.citedreferenceKleopa KA, Sherman M, Neal B, Romano GJ, Heiman‐Patterson T. Bipap improves survival and rate of pulmonary function decline in patients with ALS. J Neurol Sci 1999; 164: 82 – 88.en_US
dc.identifier.citedreferenceGruis KL, Brown DL, Lisabeth LD, Zebarah VA, Chervin RD, Feldman EL. Longitudinal assessment of noninvasive positive pressure ventilation adjustments in ALS patients. J Neurol Sci 2006; 247: 59 – 63.en_US
dc.identifier.citedreferenceBourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ. Effects of non‐invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol 2006; 5: 140 – 147.en_US
dc.identifier.citedreferenceBourke SC, Bullock RE, Williams TL, Shaw PJ, Gibson GJ. Noninvasive ventilation in ALS: indications and effect on quality of life. Neurology 2003; 61: 171 – 177.en_US
dc.identifier.citedreferenceLyall RA, Donaldson N, Fleming T, Wood C, Newsom‐Davis I, Polkey MI, et al. A prospective study of quality of life in ALS patients treated with noninvasive ventilation. Neurology 2001; 57: 153 – 156.en_US
dc.identifier.citedreferenceCarratu P, Spicuzza L, Cassano A, Maniscalco M, Gadaleta F, Lacedonia D, et al. Early treatment with noninvasive positive pressure ventilation prolongs survival in Amyotrophic Lateral Sclerosis patients with nocturnal respiratory insufficiency. Orphanet J Rare Dis 2009; 4: 10.en_US
dc.identifier.citedreferenceMiller RG, Rosenberg JA, Gelinas D, Mitsumoto H, Newman D, Sufit R, et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence‐based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology 1999; 52: 1311 – 1323.en_US
dc.identifier.citedreferenceMiller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence‐based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009; 73: 1218 – 1226.en_US
dc.identifier.citedreferenceClinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation–a consensus conference report. Chest 1999; 116: 521 – 534.en_US
dc.identifier.citedreferenceBradley WG, Anderson F, Gowda N, Miller RG. Changes in the management of ALS since the publication of the AAN ALS practice parameter 1999. Amyotroph Lateral Scler Other Motor Neuron Disord 2004; 5: 240 – 244.en_US
dc.identifier.citedreferenceDe Troyer A, Kirkwood PA, Wildon TA. Respiratory action of the intercostal muscles. Physiol Rev 2005; 85: 717 – 756.en_US
dc.identifier.citedreferenceGoldman MD, Loh L, Sears TA. The respiratory activity of human levator costae muscles and its modification by posture. J Physiol 1985; 362: 189 – 204.en_US
dc.identifier.citedreferenceDe Troyer A, Sampson MG. Activation of the parasternal intercostals during breathing efforts in human subjects. J Appl Physiol 1982; 52: 524 – 529.en_US
dc.identifier.citedreferenceLoring SH. Action of human respiratory muscles inferred from finite element analysis of rib cage. J Appl Physiol 1992; 72: 1461 – 1465.en_US
dc.identifier.citedreferenceATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med 2002; 166: 518 – 624.en_US
dc.identifier.citedreferenceFallat RJ, Jewitt B, Bass M, Kamm B, Norris FH Jr. Spirometry in amyotrophic lateral sclerosis. Arch Neurol 1979; 36: 74 – 80.en_US
dc.identifier.citedreferenceSchiffman PL, Belsh JM. Pulmonary function at diagnosis of amyotrophic lateral sclerosis. Rate of deterioration. Chest 1993; 103: 508 – 513.en_US
dc.identifier.citedreferenceGruis KL, Brown DL, Schoennemann A, Zebarah VA, Feldman EL. Predictors of noninvasive ventilation tolerance in patients with amyotrophic lateral sclerosis. Muscle Nerve 2005; 32: 808 – 811.en_US
dc.identifier.citedreferenceLechtzin N, Wiener CM, Shade DM, Clawson L, Diette GB. Spirometry in the supine position improves the detection of diaphragmatic weakness in patients with amyotrophic lateral sclerosis. Chest 2002; 121: 436 – 442.en_US
dc.identifier.citedreferenceMendoza M, Gelinas DF, Moore DH, Miller RG. A comparison of maximal inspiratory pressure and forced vital capacity as potential criteria for initiating non‐invasive ventilation in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2007; 8: 106 – 111.en_US
dc.identifier.citedreferenceLyall RA, Donaldson N, Polkey MI, Leigh PN, Moxham J. Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain 2001; 124: 2000 – 2013.en_US
dc.identifier.citedreferenceHart N, Polkey MI, Sharshar T, Falaize L, Fauroux B, Raphael JC, et al. Limitations of sniff nasal pressure in patients with severe neuromuscular weakness. J Neurol Neurosurg Psychiatry 2003; 74: 1685 – 1687.en_US
dc.identifier.citedreferenceBeck M, Giess R, Wurffel W, Magnus T, Ochs G, Toyka KV. Comparison of maximal voluntary isometric contraction and Drachman's hand‐held dynamometry in evaluating patients with amyotrophic lateral sclerosis. Muscle Nerve 1999; 22: 1265 – 1270.en_US
dc.identifier.citedreferencePinto A, De CM, Evangelista T, Lopes A, Sales‐Luis L. Nocturnal pulse oximetry: a new approach to establish the appropriate time for non‐invasive ventilation in ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord 2003; 4: 31 – 35.en_US
dc.identifier.citedreferenceLechtzin N, Scott Y, Busse AM, Clawson LL, Kimball R, Wiener CM. Early use of non‐invasive ventilation prolongs survival in subjects with ALS. Amyotroph Lateral Scler 2007; 8: 185 – 188.en_US
dc.identifier.citedreferenceJaye J, Chatwin M, Dayer M, Morrell MJ, Simonds AK. Autotitrating versus standard noninvasive ventilation: a randomised crossover trial. Eur Respir J 2009; 33: 566 – 571.en_US
dc.identifier.citedreferenceNavalesi P, Fanfulla F, Frigerio P, Gregoretti C, Nava S. Physiologic evaluation of noninvasive mechanical ventilation delivered with three types of masks in patients with chronic hypercapnic respiratory failure. Crit Care Med 2000; 28: 1785 – 1790.en_US
dc.identifier.citedreferenceLechtzin N, Weiner CM, Clawson L. A fatal complication of noninvasive ventilation. N Engl J Med 2001; 344: 533.en_US
dc.identifier.citedreferenceBach JR, Alba AS. Management of chronic alveolar hypoventilation by nasal ventilation. Chest 1990; 97: 52 – 57.en_US
dc.identifier.citedreferenceGay PC, Edmonds LC. Severe hypercapnia after low‐flow oxygen therapy in patients with neuromuscular disease and diaphragmatic dysfunction. Mayo Clin Proc 1995; 70: 327 – 330.en_US
dc.identifier.citedreferenceMelo J, Homma A, Iturriaga E, Frierson L, Amato A, Anzueto A, et al. Pulmonary evaluation and prevalence of non‐invasive ventilation in patients with amyotrophic lateral sclerosis: a multicenter survey and proposal of a pulmonary protocol. J Neurol Sci 1999; 169: 114 – 117.en_US
dc.identifier.citedreferenceRoberts F. Respiratory physiology. Update in Anaesthesia 2000; 1 – 3.en_US
dc.identifier.citedreferenceHillberg RE, Johnson DC. Noninvasive ventilation. N Engl J Med 1997; 337: 1746 – 1752.en_US
dc.identifier.citedreferenceBerry RB, Chediak A, Brown LK, Finder J, Gozal D, Iber C, et al. Best clinical practices for the sleep center adjustment of noninvasive positive pressure ventilation (NPPV) in stable chronic alveolar hypoventilation syndromes. J Clin Sleep Med 2010; 6: 491 – 509.en_US
dc.identifier.citedreferencePeysson S, Vandenberghe N, Philit F, Vial C, Petitjean T, Bouhour F, et al. Factors predicting survival following noninvasive ventilation in amyotrophic lateral sclerosis. Eur Neurol 2008; 59: 164 – 171.en_US
dc.identifier.citedreferenceButz M, Wollinsky KH, Wiedemuth‐Catrinescu U, Sperfeld A, Winter S, Mehrkens HH, et al. Longitudinal effects of noninvasive positive‐pressure ventilation in patients with amyotrophic lateral sclerosis. Am J Phys Med Rehabil 2003; 82: 597 – 604.en_US
dc.identifier.citedreferenceJanssens JP, Howarth‐Frey C, Chevrolet JC, Abajo B, Rochat T. Transcutaneous PC02 to monitor noninvasive mechanical ventilation in adults: assessment of a new transcutaneous PC02 device. Chest 1998; 113: 768 – 773.en_US
dc.identifier.citedreferenceChai CL, Pathinathan A, Smith B. Continuous positive airway pressure delivery interfaces for obstructive sleep apnoea. Cochrane Database of Systematic Reviews 2006(4)CD005308. DOI: 10.1002/14651858.CD005308.pub2.en_US
dc.identifier.citedreferenceBrown DL, Concannon M, Kaye AB, Zupancic M, Lisabeth LD. Comparison of two headgear systems for sleep apnea treatment of stroke patients. Cerebrovasc Dis 2009; 27: 183 – 186.en_US
dc.identifier.citedreferenceCriner GJ, Brennan K, Travaline JM, Kreimer D. Efficacy and compliance with noninvasive positive pressure ventilation in patients with chronic respiratory failure. Chest 1999; 116: 667 – 675.en_US
dc.identifier.citedreferenceAboussouan LS, Khan SU, Banerjee M, Arroliga AC, Mitsumoto H. Objective measures of the efficacy of noninvasive positive‐pressure ventilation in amyotrophic lateral sclerosis. Muscle Nerve 2001; 24: 403 – 409.en_US
dc.identifier.citedreferenceLo Coco D, Marchese S, Pesco MC, La Bella V, Piccoli F, Lo Coco A. Noninvasive positive‐pressure ventilation in ALS: predictors of tolerance and survival. Neurology 2006; 67: 761 – 765.en_US
dc.identifier.citedreferenceMeyer TJ, Pressman MR, Benditt J, McCool FD, Millman RP, Natarajan R, et al. Air leaking through the mouth during nocturnal nasal ventilation: effect on sleep quality. Sleep 1997; 20: 561 – 569.en_US
dc.identifier.citedreferenceTuggey JM, Delmastro M, Elliott MW. The effect of mouth leak and humidification during nasal non‐invasive ventilation. Respir Med 2007; 101: 1874 – 1879.en_US
dc.identifier.citedreferenceBachour A, Hurmerinta K, Maasilta P. Mouth closing device (chinstrap) reduces mouth leak during nasal CPAP. Sleep Med 2004; 5: 261 – 267.en_US
dc.identifier.citedreferenceCooper‐Knock J, Ahmedzai SH, Shaw P. The use of subcutaneous glycopyrrolate in the management of sialorrhoea and facilitating the use of non‐invasive ventilation in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2011; 12: 464 – 465.en_US
dc.identifier.citedreferenceMiller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence‐based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009; 73: 1227 – 1233.en_US
dc.identifier.citedreferencePinto A, Almeida JP, Pinto S, Pereira J, Oliveira AG, de Carvalho M. Home telemonitoring of non‐invasive ventilation decreases healthcare utilisation in a prospective controlled trial of patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2010; 81: 1238 – 1242.en_US
dc.identifier.citedreferenceBach JR. Update and perspective on noninvasive respiratory muscle aids. Part 2: the expiratory aids. Chest 1994; 105: 1538 – 1544.en_US
dc.identifier.citedreferenceBach JR, Ishikawa Y, Kim H. Prevention of pulmonary morbidity for patients with Duchenne Muscular Dystrophy. Chest 1997; 112: 1024 – 1028.en_US
dc.identifier.citedreferenceBach JR. Amyotrophic lateral sclerosis: predictors for prolongation of life by noninvasive respiratory aids. Arch Phys Med Rehabil 1995; 76: 828 – 832.en_US
dc.identifier.citedreferenceSancho J, Servera E, Diaz J, Marin J. Predictors of ineffective cough during a chest infection in patients with stable amyotrophic lateral sclerosis. Am J Respir Crit Care Med 2007; 175: 1266 – 1271.en_US
dc.identifier.citedreferenceMustfa N, Aiello M, Lyall RA, Nikoletou D, Olivieri D, Leigh PN, et al. Cough augmentation in amyotrophic lateral sclerosis. Neurology 2003; 61: 1285 – 1287.en_US
dc.identifier.citedreferenceTzeng AC, Bach JR. Prevention of pulmonary morbidity for patients with neuromuscular disease. Chest 2000; 118: 1390 – 1396.en_US
dc.identifier.citedreferenceWinck JC, Goncalves MR, Lourenco C, Viana P, Almeida J, Bach JR. Effects of mechanical insufflation‐exsufflation on respiratory parameters for patients with chronic airway secretion encumbrance. Chest 2004; 126: 774 – 780.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
23282_ftp.pdf
Size:
425.0KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.